ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…

latest posts
ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

BREAKING_New Long Term Faricimab Data Boosts Drug’s Profile for nAMD, DME and RVO 02
February 9, 2024

New Long-Term Faricimab Data Boosts Drug’s Profile for nAMD, DME and RVO

Enlarged,Eye,Of,Tax,Inspector,And,Financial,Auditor,Looking,Through
April 14, 2023

Keeping a Lookout for New and Emerging Therapies for AMD and DME

shutterstock_1239482932_1000
December 19, 2022

Asia-Pacific Vitreoretinal Surgeons React to PULSAR and PHOTON Trials’ Anti-VEGF New Dosing Results

shutterstock_371195909_1000
December 16, 2022

Reaching for the Stars with Aflibercept 8 mg Trial Result Release

Shutterstock_772350676
September 19, 2022

Aflibercept 8mg Extended Injection Interval Set to Reduce Treatment Burden for nAMD and DME

Progress,And,The,Way,Forward,As,A,Successful,Business,3d
September 2, 2022

EURETINA 2022 LIVE Coverage: A Paradigm Shift in Managing Diabetic Macular Edema

shutterstock_1482364103
February 26, 2022

An Alternative to Anti-VEGF for DME Emerges

Discover our fascinating content at issuu

explore